HealthDay News — The direct and indirect costs of psoriasis causes up to $135 billion a year, according to research published in JAMA Dermatology.

“Defining the US economic burden of psoriasis is needed because it provides the foundation for research, advocacy, and educational efforts,” wrote Elizabeth A. Brezinski, MD, of the University of California Davis, in Sacramento, Calif., and colleagues.

About 3.2% of the United States population has psoriasis. To determine the total annual cost of psoriasis to Americans, the researchers analyzed 22 studies from January 2008 through September 2013.

After calculating health care and other costs associated with the skin condition, the study authors found that the country spends between $112 billion and $135 billion in 2013. Direct costs of psoriasis ranged from $51.7 billion to $63.2 billion, and indirect costs — such as missed work days — ranged from $23.9 billion to $35.4 billion.

Other health problems related to psoriasis cost more than $36.4 billion, and treating the physical and mental health effects of psoriasis cost up to $11,498 per patient.

“The direct health care costs are significantly greater for patients with psoriasis than for the general population and are also higher for patients with increasing psoriasis disease severity,” wrote the researchers.


  1. Brezinkski EA et al. JAMA Dermatol. 2015; doi: 10.1001/jamadermatol.2014.3593